Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Current Assets (2016 - 2026)

Mimedx's Current Assets history spans 17 years, with the latest figure at $240.3 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 20.1% to $240.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $240.3 million, a 20.1% increase, with the full-year FY2025 number at $277.5 million, up 44.6% from a year prior.
  • Current Assets hit $240.3 million in Q1 2026 for Mimedx, down from $277.5 million in the prior quarter.
  • Over the last five years, Current Assets for MDXG hit a ceiling of $277.5 million in Q4 2025 and a floor of $131.0 million in Q2 2022.
  • Historically, Current Assets has averaged $175.2 million across 5 years, with a median of $154.5 million in 2023.
  • Biggest five-year swings in Current Assets: dropped 11.3% in 2022 and later soared 47.61% in 2025.
  • Tracing MDXG's Current Assets over 5 years: stood at $134.2 million in 2022, then grew by 22.4% to $164.3 million in 2023, then grew by 16.82% to $191.9 million in 2024, then soared by 44.6% to $277.5 million in 2025, then dropped by 13.39% to $240.3 million in 2026.
  • Business Quant data shows Current Assets for MDXG at $240.3 million in Q1 2026, $277.5 million in Q4 2025, and $254.1 million in Q3 2025.